Paritaprevir

From WikiMD.org
Jump to navigation Jump to search

Paritaprevir

Paritaprevir (pronounced as pah-ri-ta-pre-vir) is a Hepatitis C antiviral drug that is used in combination with other medications to treat chronic (long-lasting) hepatitis C, a viral infection of the liver. It works by decreasing the amount of hepatitis C virus (HCV) in the body. Paritaprevir is in a class of medications called HCV protease inhibitors.

Etymology

The name "Paritaprevir" is derived from parts of the words 'protease inhibitor', 'antiviral', and 'hepatitis C virus', which describe the drug's function and target.

Usage

Paritaprevir is used with ribavirin and other medications to treat hepatitis C in adults. It is taken orally, usually once daily. It is included in the combination drug product Viekira Pak, which also contains ombitasvir, dasabuvir, and ritonavir.

Side Effects

Common side effects of Paritaprevir include fatigue, nausea, itching, skin rash, sleep problems, and weakness. Severe side effects may include liver problems, allergic reactions, and increased susceptibility to infections.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski